| Literature DB >> 34684729 |
Yuting Sun1,2,3, Huiru Tang3, Yulan Wang4.
Abstract
Carbonyl-containing metabolites widely exist in biological samples and have important physiological functions. Thus, accurate and sensitive quantitative analysis of carbonyl-containing metabolites is crucial to provide insight into metabolic pathways as well as disease mechanisms. Although reversed phase liquid chromatography electrospray ionization mass spectrometry (RPLC-ESI-MS) is widely used due to the powerful separation capability of RPLC and high specificity and sensitivity of MS, but it is often challenging to directly analyze carbonyl-containing metabolites using RPLC-ESI-MS due to the poor ionization efficiency of neutral carbonyl groups in ESI. Modification of carbonyl-containing metabolites by a chemical derivatization strategy can overcome the obstacle of sensitivity; however, it is insufficient to achieve accurate quantification due to instrument drift and matrix effects. The emergence of stable isotope-coded derivatization (ICD) provides a good solution to the problems encountered above. Thus, LC-MS methods that utilize ICD have been applied in metabolomics including quantitative targeted analysis and untargeted profiling analysis. In addition, ICD makes multiplex or multichannel submetabolome analysis possible, which not only reduces instrument running time but also avoids the variation of MS response. In this review, representative derivatization reagents and typical applications in absolute quantification and submetabolome profiling are discussed to highlight the superiority of the ICD strategy for detection of carbonyl-containing metabolites.Entities:
Keywords: RPLC-ESI-MS; absolute quantification; carbonyl-containing metabolites; stable isotope-coded derivatization; submetabolome profiling
Mesh:
Substances:
Year: 2021 PMID: 34684729 PMCID: PMC8541004 DOI: 10.3390/molecules26206147
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Key factors of an excellent chemical derivatization reagent.
Figure 2Classic reactions of carbonyl compounds.
Figure 3Mechanism of imine formation.
Scheme 1The E-/Z-isomers of HMP-derivatized carbonyl-containing metabolites.
Figure 4The scheme and chromatogram of oxime derivatives obtained by (a) pre-column derivatization and (b) post-column derivatization.
Scheme 2Pathway for imine formation and reduction using aldehydes and 4-APC.
Summary of ICD reagents for carbonyl-containing metabolites and their applications.
| Reagent | ICD Reagent | Analytes | Matrix | Application | Year & Ref. |
|---|---|---|---|---|---|
| HMP | d3-HMP | Brain neurosteroids | Rat brain | Differential and quantitative analysis of the changes in the brain neurosteroids levels by immobilization stress and antipsychotic drug administration | 2016 [ |
| GP | d5-GP | Steroid hormones | Human follicular fluid | Quantitative analysis of androgenic and progestagenic steroids in polycystic ovarian syndrome patients compared with healthy controls | 2016 [ |
| QAO | d3-QAO | Ketosterols | Human plasma and dried blood spots | Sensitive isotope dilution quantification of 7αC4 and 7α12αC4 between CTX and unaffected samples | 2014 [ |
| MOA | d3-MOA | Ketosteroids hormones | Meat | Sensitive and accurate quantification of ketosteroids hormones in meat using MRM scan mode | 2015 [ |
| 3-NPH | 13C6-3-NPH | MDA | Human plasma | Quantification of MDA in major depressive disorder patients | 2016 [ |
| MPIA | d3-MPIA | Aliphatic aldehydes | Aquatic products | Quantification of aliphatic aldehydes in aquatic products | 2014 [ |
| Ammonium | 15N-ammonium acetate and PQ | HNE & HHE | Human serum | Simultaneous determination of HNE and HHE in the serum of healthy controls and pathological conditions | 2018 [ |
| Acetylacetone | d8-acetylacetone | Formaldehyde | Personal-care products | Accurate quantification of formaldehyde in children’s personal-care products | 2017 [ |
| Pyridine | d5-pyridine | Fatty aldehydes | Human thyroid carcinoma and para-carcinoma | Identification and quantification of free fatty aldehydes in the human thyroid tissue | 2016 [ |
| Aniline | 13C6-aniline | Carbonyl-containing | Cell-free protein synthesis | Absolute quantification of cell-free protein synthesis metabolism | 2019 [ |
| Dns-Hz | 13C2-Dns-Hz | Carbonyl | Human urine | Profiling the carbonyl submetabolome in human urine | 2017 [ |
| QDA | 13CD3-QDA | Carbonyl metabolites | Tissue and cells extraction | Profiling and quantification of carbonyl metabolites | 2012 [ |
| T3 | D3 | Fatty aldehydes | Rat plasma and brain tissue | Discovery and comprehensive characterization of endogenous fatty aldehydes in rat plasma and brain tissue | 2016 [ |
| 4-APC | d4-4-APC | Aldehydes | Human urine and white wine | Identification of potential aldehyde-containing compounds in human urine and white wine | 2015 [ |
| HIQB | d7-HIQB | Carbonyl compounds | Human serum | Profiling and quantitation of carbonyl compounds in human serum between myelogenous leukemia patients and healthy controls | 2017 [ |
| DNPH | d3-DNPH | Carbonyl compounds | Saliva | Simultaneous identification and relative quantification of carbonyls in human biological fluids | 2017 [ |
Figure 5General workflow of the ICD strategy for the absolute quantification.
Scheme 3Reaction strategy for simultaneous quantification of sterol and oxysterol.
Figure 6The scheme for profiling of carbonyl compounds using HIQB/d7-HIQB.
Figure 7(a) Scheme of HRAM-DDA MS3 neutral loss screening strategy; (b) classification scheme for characterizing known and unknown DNPH-derivatized carbonyls. Adapted with permission from [135]. Copyright 2017 American Chemical Society.